|  Help  |  About  |  Contact Us

Publication : Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.

First Author  Chung L Year  2018
Journal  Neurobiol Dis Volume  110
Pages  12-19 PubMed ID  29097328
Mgi Jnum  J:268451 Mgi Id  MGI:6267117
Doi  10.1016/j.nbd.2017.10.016 Citation  Chung L, et al. (2018) Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model. Neurobiol Dis 110:12-19
abstractText  Epilepsy is prevalent and often medically intractable in Angelman syndrome (AS). AS mouse model (Ube3a(m-/p+)) shows reduced excitatory neurotransmission but lower seizure threshold. The neural mechanism linking the synaptic dysfunction to the seizure remains elusive. We show that the local circuits of Ube3a(m-/p+)in vitro are hyperexcitable and display a unique epileptiform activity, a phenomenon that is reminiscent of the finding in fragile X syndrome (FXS) mouse model. Similar to the FXS model, lovastatin suppressed the epileptiform activity and audiogenic seizures in Ube3a(m-/p+). The in vitro model of Ube3a(m-/p+) is valuable for dissection of neural mechanism and epilepsy drug screening in vivo.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression